Macrogenics (MGNX) Change in Account Payables (2012 - 2017)
Macrogenics (MGNX) posted quarterly Change in Account Payables of $197000.0 for Q2 2017, up 496.97% year-over-year from $33000.0 in Q2 2016, and up 108.86% quarter-over-quarter from -$2.2 million in Q1 2017.
Macrogenics (MGNX) Change in Account Payables (2012 - 2017) Analysis & Trends
Macrogenics (MGNX) has reported Change in Account Payables for 6 consecutive years, with $197000.0 the latest figure, recorded in Q2 2017.
- In Q2 2017, Change in Account Payables rose 496.97% year-over-year to $197000.0; the TTM figure through Jun 2017 stood at $561000.0 (up 179.91% YoY), while the FY2025 annual figure was -$280000.0, up 81.7% from the prior year.
- Change in Account Payables improved to $197000.0 in Q2 2017 per MGNX's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.4 million in Q4 2016 and bottomed at -$2.7 million in Q4 2014.
- Historically, Change in Account Payables has averaged -$112611.1 across 5 years, with a median of -$96000.0 in 2015.
- On a YoY basis, Change in Account Payables climbed as much as 496.97% in 2017 and fell as far as 472.94% in 2017.
- Macrogenics' Change in Account Payables stood at $1.4 million in 2013, then slumped by 298.32% to -$2.7 million in 2014, then surged by 61.93% to -$1.0 million in 2015, then surged by 328.5% to $2.4 million in 2016, then sank by 91.67% to $197000.0 in 2017.
- Business Quant data shows MGNX's Change in Account Payables at $197000.0 in Q2 2017, -$2.2 million in Q1 2017, and $2.4 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Macrogenics | 268.22 Mn | 201.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 197,000.00 |
| Jun 30, 2017 | 197,000.00 |
| Mar 31, 2017 | -2.22 Mn |
| Mar 31, 2017 | -2.22 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Sep 30, 2016 | 222,000.00 |
| Sep 30, 2016 | 222,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Dec 31, 2015 | -1.04 Mn |
| Dec 31, 2015 | -1.04 Mn |
| Sep 30, 2015 | 688,000.00 |
| Sep 30, 2015 | 688,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | -225,000.00 |
| Mar 31, 2015 | -225,000.00 |